| Description |
1 online resource : illustrations |
| Contents |
ADVANCES IN MEDICINE AND BIOLOGY. VOLUME 18; ADVANCES IN MEDICINE AND BIOLOGY. VOLUME 18; CONTENTS; PREFACE; STUDY OF MYELOPROTECTIVE ACTIVITYOF PHARMACOLOGICAL AGENT NOVOGEN, UNDER CONDITIONS OF DURABLE INFLUENCEOF CHLORAMPHENICOL ON ORGANISM; INVESTIGATION MATERIALS AND METHODS; REFERENCES; ASSESSMENT OF SERUM ASCORBIC ACID LEVELSIN SOME SELECTED SURGICAL DISEASESAND IMPLICATIONS FOR WOUND HEALINGAND SURGERY- INDUCED OXIDATIVE STRESS; ABSTRACT; INTRODUCTION; PATIENTS AND METHODS; Patients and Study Design; Serum Sample Collection and Preparation; Assay for Serum Ascorbic Acid |
|
Statistical AnalysisEthics; RESULTS; DISCUSSION; REFERENCES; INDICATIONS AND MANAGEMENT OF M-TORINHIBITORS AFTER LIVER TRANSPLANTATION; ABSTRACT; INTRODUCTION; Objectives; MATERIAL AND METHODS; DEMOGRAPHIC CHARACTERISTICS; Data Analysis; RESULTS; Efficacy; Liver Graft Function after Conversion; Side Effects and Discontinuation; Pharmacokinetics; Patient Survival and Follow-Up; DISCUSSION; REFERENCES; LIVER TRANSPLANTATION: THERAPY; INTRODUCTION; ACUTE CELLULAR REJECTION; Allograft Recognition; T-Cell Activation; Clonal Expansion; Inflammation; IMMUNOSUPPRESSIVE AGENTS |
|
USE OF IMMUNOSUPPRESSIVE AGENTS IN LIVER TRANSPLANTATIONIN THE UNITED STATES. CALCINEURIN INHIBITORS-CYCLOSPORINE AND TACROLIMUS; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; CORTICOSTEROIDS; Background; Mechanism of Action; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; RAPAMYCIN; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; PURINE SYNTHESIS INHIBITORS |
|
MYCOPHENOLATE MOFETILBackground; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; ANTILYMPHOCYTIC ANTIBODY THERAPY; MONOCLONAL ANTI-T- CELL RECEPTOR ANTIBODIES; Background/Discover; Mechanism of Action; Pharmcokinetics and Pharmocodynamics; Side Effects; Clinical use; POLYCLONAL ANTIBODIES; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Clinical use; ALEMTUZUMAB/CAMPATH-1-H; INTERLEUKIN-2 RECEPTOR ANTIBODIES; Mechanism of Action; Pharmacokinetics and Pharmacodynamics |
|
Clinical useIMMUNOSUPPRESSANTS IN DEVELOPMENT; FK 778; JAK3 Inhibitors; FTY 720; BELATACEPT-COSTIMULATORY SIGNAL BLOCKADE; SUMMARY; REFERENCES; HISTOPATHOLOGICAL ANDIMMUNOHISTOCHEMICAL BACKGROUNDOF ORTHODONTIC TREATMENT; ABSTRACT; INTRODUCTION; DEVELOPING MANDIBULAR BODY BONE; DEVELOPING MANDIBULAR CARTILAGES; REGULATION FACTORS IN MORPHOGENESIS OF MANDIBULARCONDYLAR CARTILAGE; PERIODONTAL TISSUE REACTIONS IN ORTHODONTIC TREATMENT; PERIODONTAL TISSUE REACTION TO CELL INJURY STIMULATION; REFERENCES; REPERCUSSION OF MYTHS, BELIEFS AND PRACTICESON CHILDREN'S ORAL HEALTH; SUMMARY; INTRODUCTION |
| Notes |
"Nova biomedical." |
| Bibliography |
Includes bibliographical references |
| Notes |
Print version record |
| Subject |
Medicine -- Research.
|
|
MEDICAL -- Allied Health Services -- Medical Technology.
|
|
MEDICAL -- Biotechnology.
|
|
MEDICAL -- Family & General Practice.
|
|
MEDICAL -- Lasers in Medicine.
|
|
TECHNOLOGY & ENGINEERING -- Biomedical.
|
|
Medicine -- Research
|
| Form |
Electronic book
|
| Author |
Berhardt, Leon V.
|
| ISBN |
9781612094953 |
|
1612094953 |
|
